Nav: Home

Barrow researchers prove utility of imaging tool in surgeon's hand

May 03, 2016

(May 3, 2016 Phoenix, Ariz.) -- Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room -- a finding that could have important implications for identifying and locating invading cells at the edge of a brain tumor. The research, led by neurosurgeons, Drs. Mark Preul, Nikolay Martirosyan, Peter Nakaji, and Jennifer Eschbacher, was published in the April issue of Neurosurgical Focus.

Dr. Preul directs the Neurosurgery Research Laboratory of the Barrow Neurosurgical Institute, which has carried out the pioneer work in applying and developing confocal laser endomicroscopy for brain tumors. His research largely focuses on new means to incorporate imaging methods to view cells of brain tumors with a hand held instrument that a neurosurgeon can use to visualize the individual cells during the progress of the operation. On the fly, neurosurgeons can use the pen-sized instrument on the brain to view the tumor cells with unique fluorescent characteristics that outline the tumor cells. Images of the tumor cells are immediately created on an LCD screen observed as the surgeon scans the instrument across the tumor or brain surface. In the first study to compare use of the confocal laser endomicroscope to frozen section biopsy, the endomicroscope images could identify and characterize the tumor tissue as well as sampling the tissue, or, frozen section biopsy.

"For the first time we have an instrument that can visualize the cells of the tumor as we are operating on the brain. We can immediately detect a region that harbors tumor, and see the border of the brain tumor. This is especially beneficial for malignant tumors where the amount of tumor removed may play a huge part in the survival time of the patient. This is personalized medicine on the surgical front with a new imaging tool in the surgeon's hand," says Dr. Preul.

The research was conducted in the neurosurgery department of the Barrow Neurological Institute. Preul and the team came to their results by using the confocal laser endomicroscope on 74 brain tumor patients. The research was funded by the Barrow Neurological Foundation.

The eventual goal of this research is to develop the instrument to a degree that it is FDA approved and can speed up the process of pathology interpretation of brain tumor tissue. Hopefully this technology will improve brain tumor surgery by allowing for a more tailored removal of the tissue and allowing for more aggressive management at the tumor border.

Next steps for this research will see new refinements in the endomicroscope instrument and development of new tumor cell stains and probes that light up the tumor cells to an even greater degree.

St. Joseph's Hospital and Medical Center

Related Brain Tumor Articles:

New target found to attack an incurable brain tumor in children
Research shows that a tumor suppressor gene p16 is turned off by a histone mutation (H3.3K27M), which is found in up to 70 percent of childhood brain tumors called diffuse intrinsic pontine glioma (DIPG).
Treatment of malignant brain tumor in children gets closer
Researchers at the University of Copenhagen have identified important mechanisms underlying how a special type of malignant brain tumor arises in children.
Molecule stops fatal pediatric brain tumor
Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor.
Tumor-seeking salmonella treats brain tumors
Genetic tweaks to salmonella turn the bacteria into cancer-seeking missiles that produce self-destruct orders deep within tumors.
Molecular signature for aggressive brain tumor uncovered
Researchers from Brigham and Women's Hospital, in collaboration with colleagues at Massachusetts General Hospital, have identified genetic mutations that can distinguish aggressive rhabdoid meningiomas from more benign forms using routine laboratory tests.
Brain tumor characteristics could help predict survival in people over 70
Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research* presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool.
Key mechanism identified in brain tumor growth
A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.
Laser treatment may boost effectiveness of brain tumor drugs
The human brain has a remarkable defense system that filters bacteria and chemicals.
Genetic cause identified in rare pediatric brain tumor
Researchers found a way of differentiating angiocentric gliomas from other low-grade pediatric brain tumors and developed a pathological test that will help children avoid unnecessary and potentially damaging additional therapies.
New way to identify brain tumor aggressiveness
A comprehensive analysis of the molecular characteristics of gliomas -- the most common malignant brain tumor -- explains why some patients diagnosed with slow-growing (low-grade) tumors quickly succumb to the disease while others with more aggressive (high-grade) tumors survive for many years.

Related Brain Tumor Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...